[{"notes_id":"1_2724","category":"9","subcategory":"1","title":"SSRI: side-effects","body":"Adverse effects<br \/><ul><li>gastrointestinal symptoms are the most common side-effect<\/li><li>there is an increased risk of gastrointestinal bleeding in patients taking SSRIs. A proton pump inhibitor should be prescribed if a patient is also taking a NSAID<\/li><li><span class=\"concept\" data-cid=\"5738\">hyponatraemia<\/span><\/li><li>patients should be counselled to be vigilant for increased anxiety and agitation after starting a SSRI<\/li><li>fluoxetine and paroxetine have a higher propensity for drug interactions<\/li><\/ul><br \/>Citalopram and the QT interval<br \/><ul><li>the Medicines and Healthcare products Regulatory Agency (MHRA) released a warning on the use of citalopram in 2011<\/li><li>it advised that citalopram and escitalopram are associated with dose-dependent QT interval prolongation and should not be used in those with: congenital long QT syndrome; known pre-existing QT interval prolongation; or in combination with other medicines that prolong the QT interval<\/li><li>the maximum daily dose is now 40 mg for adults; 20 mg for patients older than 65 years; and 20 mg for those with hepatic impairment<\/li><\/ul><br \/>Interactions<br \/><ul><li>NSAIDs: NICE guidelines advise 'do not normally offer SSRIs', but if given co-prescribe a proton pump inhibitor<\/li><li>warfarin \/ heparin: NICE guidelines recommend avoiding SSRIs and considering mirtazapine<\/li><li>aspirin: see above<\/li><li>triptans: avoid SSRIs<\/li><\/ul><br \/>Following the initiation of antidepressant therapy patients should normally be reviewed by a doctor after 2 weeks. For patients under the age of 30 years or at increased risk of suicide they should be reviewed after 1 week. If a patient makes a good response to antidepressant therapy they should continue on treatment for at least 6 months after remission as this reduces the risk of relapse. <br \/><br \/>When stopping a SSRI the dose should be gradually reduced over a 4 week period (this is not necessary with fluoxetine). Paroxetine has a higher incidence of discontinuation symptoms.<br \/><br \/>Discontinuation symptoms<br \/><ul><li>increased mood change<\/li><li>restlessness<\/li><li>difficulty sleeping<\/li><li>unsteadiness<\/li><li>sweating<\/li><li>gastrointestinal symptoms: pain, cramping, diarrhoea, vomiting<\/li><li>paraesthesia<\/li><\/ul>","notes_hash":"3669924656e06265ec849939cee14314","knowledge_graph_node_id_link":10859,"links":"","media":"","concepts_for_notes":{"5738":{"concept_text":"SSRIs are associated with hyponatraemia","concept_percentile":"57"}},"category_name":"Psychiatry \/ Neurology","subcategory_name":"Psychiatry","comment_count":5},"",[]]